Herein, we carried out a single center retrospective cohort study involving 22 pediatric FMF patients treated with anti-IL1 agents to evaluate their long-term growth response to treatment in addition to assessment the overall efficacy and safety of these agents. The gene discussed is IL1B; the disease is familial Mediterranean fever.